Porn Addiction Medication: What the Evidence Actually Says - X Reset
All articles
Sep 15, 2026

Porn Addiction Medication: What the Evidence Actually Says

No approved pill, 13 small studies, and a medical decision that starts with what else is happening.

Ricardo Metring Ricardo Metring

You search for porn addiction medication because you want the loop to get quieter.

A pill sounds concrete. Take this, lose the urge, get your evenings back.

The evidence is not there yet.

No medication is formally approved for compulsive sexual behaviour disorder. A psychiatrist may use medication off-label, but the best review found only 13 studies and 141 people.

This article is education, not a prescription. Do not start, stop, borrow, or change psychiatric medication without the clinician who knows your history.

First, what is the doctor treating?

“Porn addiction” is the phrase people search. It is not a single medication target with a standard prescription.

The World Health Organization recognizes compulsive sexual behaviour disorder (CSBD) in ICD-11, the World Health Organization's diagnostic manual. The diagnosis is about repeated loss of control and real harm, not simply watching porn often or feeling guilty about it.

A clinician should also check what sits beside the behaviour: depression, anxiety, attention-deficit/hyperactivity disorder (ADHD), obsessive symptoms, alcohol or drug use, trauma, and bipolar symptoms.

That changes the decision. Sometimes the medication is treating the condition feeding the loop, not porn use itself.

What the medication evidence actually says

The best systematic review found 13 medication studies with 141 participants. Only one participant was a woman.

Naltrexone had the strongest signal, but only for some outcomes. The reviewers still concluded that the evidence was limited and called for better trials.

Selective serotonin reuptake inhibitors (SSRIs), including paroxetine and citalopram, have also been studied. Results were mixed, and improvement sometimes appeared in the placebo group too.

This is not a hidden cure waiting for wider use. It is a small research base trying to answer a large question.

Straight with you: 141 people across 13 studies is thinner than it sounds. Most studies were small, short, male-only, or uncontrolled.

Naltrexone is promising, not proven

Naltrexone is normally used for alcohol or opioid use disorders. Researchers tested whether reducing the reward response could also reduce compulsive sexual behaviour.

One uncontrolled study gave it to 20 men for four weeks. Scores improved during treatment, but there was no placebo group, and 19 men reported at least one side effect.

A later trial assigned 73 men to naltrexone, paroxetine, or placebo. Self-rated symptoms fell in all three groups, with no difference between them.

Clinician interviews did favor the medications on some measures. Craving fell only in the paroxetine group. That is a signal worth studying, not a clean win.

Naltrexone also matters medically because it conflicts with opioid use and can be unsafe in some liver conditions. A search result cannot screen that for you.

Why a psychiatrist may still discuss an SSRI

SSRIs are antidepressants. They may make sense when depression, anxiety, or obsessive symptoms are part of the same picture.

They can also change sexual desire, orgasm, and functioning. That side effect is not the same thing as recovery, and it can create a new problem.

The clinical guideline puts psychotherapy first. It discusses SSRIs or naltrexone only after severity, coexisting conditions, risk, and earlier treatment are considered.

Medication should make the work more possible. It does not replace the work.

Five questions to take to the appointment

  1. What diagnosis are we treating? Ask what evidence in your history supports it.
  2. Why this medication? The answer should connect to your symptoms or another diagnosed condition.
  3. What will we measure? Pick urges, viewing time, binges, sleep, mood, or another concrete baseline.
  4. Which side effects need a call? Know the urgent ones and the common ones before the first dose.
  5. When do we review the decision? A prescription without a follow-up plan is not a treatment plan.

Bring every medication, supplement, and substance you use into that conversation. Hiding the embarrassing part makes the safety check weaker.

Keep the broader plan outside the prescription too. The treatment guide covers therapy evidence, and the help guide shows where to start.

Common questions

Is there an approved pill for porn addiction?

No. Medications discussed for CSBD are used off-label. The evidence is small, and psychotherapy remains the first-choice treatment in the clinical guideline.

Does naltrexone stop porn urges?

Some small studies found improvement, but the main placebo-controlled trial found no difference between groups on self-rated overall severity. It is promising research, not a guaranteed result.

Can an antidepressant help?

Possibly, especially when depression, anxiety, or obsessive symptoms also need treatment. Benefits and sexual side effects both belong in a psychiatrist's decision.


There is no magic pill. There may be useful medical help.

Those are not the same sentence.

Take the problem seriously enough to get assessed, and take the evidence seriously enough not to prescribe yourself a cure.

Sources

  1. Borgogna, N. C., et al. (2024). No Magic Pill: A Systematic Review of the Pharmacological Treatments for Compulsive Sexual Behavior Disorder. The Journal of Sex Research.
  2. Turner, D., et al. (2022). WFSBP guidelines on the assessment and pharmacological treatment of compulsive sexual behaviour disorder. The World Journal of Biological Psychiatry.
  3. Lew-Starowicz, M., et al. (2022). Tolerability and efficacy of paroxetine and naltrexone for treatment of compulsive sexual behaviour disorder. World Psychiatry.
  4. World Health Organization. Clinical descriptions and diagnostic requirements for ICD-11 mental, behavioural or neurodevelopmental disorders.